In the present study, we found that TRIP13 also activates AKT signaling to promote melanoma malignant phenotypes which is consistent with the previous research; we further discovered that TRIP13 activates AKT signaling by directly interacting with FLNA. The gene discussed is TRIP13; the disease is melanoma.